MB11
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MB11, covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma [Phase 3]